Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Health

Results: 8317-8328 of 9404

Business Wire logo

LivaNova to Wind Down Advanced Circulatory Support Business Unit

Business Wire logo

Biocytogen Enters into Bispecific Antibody Drug Conjugate Agreement with Radiance Biopharma

Business Wire logo

Debiopharm Extends SunRock Biopharma Partnership for Antibody Drug Conjugates Targeting HER3 in EGFR Mutated Cancers

PR Newswire associated0

Novel Technology Transforms Baldness Treatment Using Beard and Body Hair

PR Newswire associated0

The World's First Clinical Base Edting Therapy for Hemoglobinopathy

Business Wire logo

MindMed Announces Business Update and Anticipated Milestones for 2024

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

PR Newswire associated0

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries

Dr. William Pao has joined Alentis Therapeutics' Board of Directors as an independent member. (Photo: Alentis Therapeutics)

William Pao Joins Alentis Therapeutics as Independent Board Member

Business Wire logo

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

  • Prev Page
  • 1
  • 2
  • …
  • 693
  • 694
  • 695
  • …
  • 783
  • 784
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us